Rznomics Inc. Q3 operating loss of KRW 6.9 billion; cumulative operating loss of KRW 21.8 billion
AI summary · Not investment advice
Algenomics sold KRW 0.4 billion in Q3 and lost KRW 6.9 billion from its main business, with a KRW 21.8 billion loss from January to September.
Operating profit · 3 months
KRW -6.9 billion
Key facts
- Revenue (3 months)
- KRW 448.7 million
- Net income (3 months)
- KRW -6.4 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 0
- Revenue (year to date)
- KRW 1.6 billion
- Operating profit (prior-year 3 months)
- KRW -8.1 billion
- Operating profit (year to date)
- KRW -21.8 billion
- Net income (prior-year 3 months)
- KRW -8.1 billion
- Net income (year to date)
- KRW -20.6 billion
Commentary
AI commentary · Not investment advice
What happened
Rgenomics filed its quarterly report for the third quarter of 2026, on a consolidated basis. Sales for the latest 3 months were KRW 448.7 million. Sales for the same 3 months a year earlier were KRW 0. Cumulative sales this year were KRW 1.62 billion.
In the company's terms
Operating profit (money earned from the core business) was a loss of KRW 6.91 billion for the latest 3 months. A year earlier, the same period showed a loss of KRW 8.08 billion. The cumulative operating loss this year is KRW 21.82 billion.
What changes for shareholders
Net income (the final profit after taxes and all other items) was a loss of KRW 6.44 billion for the latest 3 months. A year earlier, the same period showed a loss of KRW 8.15 billion. The cumulative net loss this year is KRW 20.57 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
R